Serum miR‐221 serves as a biomarker for Parkinson's disease
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is the common age‐related neurodegenerative disorder. Sensitive, noninvasive biomarkers that facilitate PD diagnosis and stage assignment are currently unavailable. This study aims to investigate the potential of 16 previous reported PD‐associated miRNAs as novel biomarkers for PD. The expression of 16 serum miRNAs was measured by quantitative reverse transcriptase polymerase chain reaction in 138 PD patients and 112 control populations. Analyses were undertaken to assess the specificity and sensitivity of miRNAs to predict PD. In addition, the relationship between deregulated miRNAs and Part III of the United Parkinson's Disease Rating Scale (UPDRS‐III) and Part V of the UPDRS (UPDRS‐V; the modified Hoehn and Yahr staging of PD) in PD patients was also assessed. It was found that the serums miR‐29c, miR‐146a, miR‐214, and miR‐221 were significantly decreased in PD patients compared with healthy control populations. In addition, serum miR‐221 was positively correlated with UPDRS‐III (r = .4702) and UPDRS‐V (r = .4788) score in PD patients. Furthermore, the receiver operating characteristic result of serum miR‐221 for prediction of PD was 0.787. Our preliminary findings indicate that downregulated serum miR‐221 might be a potential biomarker for PD evaluation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of microRNAs in vascular diseases, inflammation, and angiogenesis
Urbich, C., Kuehbacher, A., & Dimmeler, S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn156 · Cited by 880
Parkinson’s disease: genetics and pathogenesis
Shulman, J. M., De Jager, P. L., & Feany, M. B. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130242 · Cited by 801 · cited 1×
“Parkinson's disease (PD) is the second most common age‐related neurodegenerative disorder, which is largely attributable to the degeneration of dopaminergic neurons with accompanying nonmotor symptoms resulting from neuronal loss in many other brain regions.(1) Currently, a PD diagnosis mainly depends on neuroimaging…”
BackgroundmiRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease
Mushtaq, G., H. Greig, N., Anwar, F., A. Zamzami, M., Choudhry, H., M. Shaik, M., A. Tamargo, I., & A. Kamal, M. (2016) · Medicinal Chemistry · doi:10.2174/1573406411666151030112140 · Cited by 78
Cited by
Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
Mori, M. A., Ludwig, R. G., Garcia-Martin, R., Brandão, B. B., & Kahn, C. R. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.011 · Cited by 961
Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders
van den Berg, M. M. J., Krauskopf, J., Ramaekers, J. G., Kleinjans, J. C. S., Prickaerts, J., & Briedé, J. J. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101732 · Cited by 253
Fan, W., Liang, C., Ou, M., Zou, T., Sun, F., Zhou, H., & Cui, L. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00090 · Cited by 116
“The miR-146a level is decreased in peripheral blood mononuclear cells (PBMCs) and sera of patients with PD (Ma et al., 2016; Caggiu et al., 2018).”
BackgroundThe role of microRNA-485 in neurodegenerative diseases
Ryu, I. S., Kim, D. H., Cho, H.-J., & Ryu, J.-H. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0039 · Cited by 25
Metadata
- Authors
- Ma, W., Li, Y., Wang, C., Xu, F., Wang, M., & Liu, Y.
- Venue
- Cell Biochemistry and Function
- Publisher
- Wiley
- Published
- 2016-10
- Volume
- 34
- Issue
- 7
- Pages
- 511-515
- ISSN
- 0263-6484 (ISSN-L)
- 1099-0844
- OpenAlex
- W2536942571
- Cited by
- 108
- References
- 3
- FWCI
- 6.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum miR‐221 serves as a biomarker for Parkinson's disease. https://app.cochat.ai/papers/10.1002/cbf.3224
- The paper
- Ma, W., Li, Y., Wang, C., Xu, F., Wang, M., & Liu, Y. (2016). Serum miR‐221 serves as a biomarker for Parkinson's disease. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.3224
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.